Table 1 Comparison laboratory parameters between survivors and nonsurvivors patients infected with COVID-19

Mean age ± SD

50.6 ± 11.8

59.1 ± 11.9

Gender (male/female)

214/161 (57.1/42.9%)

223/152 (59.6/40.4%)

ALT, IU/L (mean ± SD) (Reference range: 5–40)

32.6 ± 14.8

31.1 ± 23.7

AST, IU/L (mean ± SD) (Reference range: 5–40)

33.9 ± 15.2

31.2 ± 17.7

ALP, IU/L (mean ± SD) (Reference range: up to 306)

177.5 ± 94.7

165.7 ± 79.8

Cholesterol, mg/dL (mean ± SD) (Reference range: 50–200)

115.5 ± 40.2

127.9 ± 49.1

TG, mg/dL (mean ± SD) (Reference range: 60–165)

129.1 ± 47.6

136.8 ± 67.1

LDL, mg/dL (mean ± SD) (Reference range: up to 150)

61.5 ± 29.1

73.3 ± 21.2

HDL, mg/dL (mean ± SD) (Reference range: > 40)

32.5 ± 12.9

32.1 ± 11.8

WBC, 10⁹/L (mean ± SD) (Reference range: 4000–10,000)

7615.4 ± 2641.2

7812.3 ± 2878.1

CRP, mg/L (mean ± SD) (Reference range: < 10 mg/L Negative)

54.9 ± 20.1

68.4 ± 20.7

ESR, mm/1st h (mean ± SD) (Reference range: 0–15)

45.8 ± 15.5

56.1 ± 15.4

FBS, mg/dL (mean ± SD) (Reference range: 70–100)

107.3 ± 41.9

106.1 ± 40.5

Platelets × 1000/cumm (mean ± SD) (Reference range: 140,000–400,000)

183 ± 67

185 ± 78

T3, ng/dL (mean ± SD) (Reference range: 2.3–4.2)

3.1 ± 1.6

2.9 ± 1.7

T4, mcg/dL (mean ± SD) (Reference range: 5.6–13.7)

8.4 ± 6.1

8.9 ± 6.3

TSH, mu/L (mean ± SD) (Reference range: 0.4–4.5)

3.2 ± 1.9

3.5 ± 2.1

Hemoglobin, g/dL (mean ± SD) (Reference range: 12–18)

12.5 ± 1.3

13.1 ± 1.7

BUN, mg/dL (mean ± SD) (Reference range: 15–45)

38.2 ± 7.9

46.2 ± 8.2

Creatinine, mg/dL (mean ± SD) (Reference range: 0.6–1.4)

1.4 ± 0.5

1.5 ± 0.7

25-hydroxy vitamin D, ng/mL (mean ± SD) (Sufficiency: 21–150)

35.7 ± 13.5

20.1 ± 9.3

Real-time PCR Ct values

28.4 ± 10.2

18.4 ± 7.4